Special Issue "Therapeutic Aspects of Gasotransmitters in Cardiovascular and Renal Disease"
Deadline for manuscript submissions: closed (21 December 2018)
Prof. Dr. Jaap A. Joles
Department of Nephrology and Hypertension, Laboratory of Renal and Vascular Biology, University Medical Center Utrecht, Utrecht, The Netherlands
Website | E-Mail
Interests: cardiorenal and renocardiac syndrome; pre-eclampsia and fetal growth retardation; developmental plasticity in relation to hypertension and renal disease; metabolic syndrome and type 2 diabetes; renal hypoxia
Gasotransmitters (NO, CO and H2S) play a central role in signal transduction via guanylate cyclase and cGMP in many tissues. Generally, their effects are vasodilatory, anti-inflammatory and anti-fibrotic. Moreover, all three inhibit mitochondrial respiration. Well-known pharmacological strategies involving NO include NO-donors for pulmonary hypertension and phosphodiesterase-inhibitors for erectile dysfunction. Sodium thiosulfate, is an H2S donor that appears useful in calciphylaxis in end-stage kidney disease. Therapeutic use of CO, for instance with CO-donors, is in its infancy. This Special Issue focuses on “Therapeutic Aspects of Gasotransmitters in Cardiovascular and Renal Disease”. Different donor compounds have a wide range of kinetics. Various compounds target signalling pathways. Tolerance is well-recognised for NO-donors but has barely been addressed for CO and H2S. The interdependency of cardiac, renal and vascular function, as well as their involvement in systemic conditions, such as diabetes and pre-eclampsia, encourage an integrative systems approach. Original studies (preclinical and clinical), with an emphasis on molecular biology and molecular medicine, as well as reviews, are all welcome.
Prof. Dr. Jaap A. Joles
Prof. Dr. Harry van Goor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access bimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- nitric oxide
- carbon monoxide
- hydrogen sulfide
- guanylate cyclase
- chronic kidney disease
- heart failure